BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8979469)

  • 1. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M; Menon M; Doctor V
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
    Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNOR counts have no prognostic value in breast cancer.
    Toikkanen S; Joensuu H
    J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions?
    Sivrides E; Anastasiadis P; von Lüdinghausen M
    Zentralbl Pathol; 1992 Apr; 138(2):103-7. PubMed ID: 1610761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.
    Derenzini M; Ceccarelli C; Santini D; Taffurelli M; Treré D
    J Clin Pathol; 2004 Jul; 57(7):755-61. PubMed ID: 15220371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors.
    Adeyemi BF; Kolude BM; Akang EE; Lawoyin JO
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):513-20. PubMed ID: 16997120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
    Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.